Show simple item record

dc.contributor.authorRourke, Michelle
dc.date.accessioned2021-12-20T03:37:47Z
dc.date.available2021-12-20T03:37:47Z
dc.date.issued2017
dc.identifier.urihttp://hdl.handle.net/10072/411064
dc.description.abstractThe purpose of this Opinion article is to inform scientists of the access and benefit-sharing (ABS) laws that could encroach on their ability to obtain pathogen samples for research purposes. The United Nations’ Convention on Biological Diversity (CBD) reaffirms the sovereign right of states over their genetic resources and recommends that access to such resources occur on mutually agreed terms and with the prior informed consent of eligible providers. This creates the conditions for a quid pro quo on genetic resources, essentially transforming them into articles of trade. The CBD cedes the authority to determine the terms of access to genetic resources, including pathogens, to national governments and this has created a patchwork of domestic ABS regulations around the globe. This article posits that the current ABS regime creates unacceptable incentives to avoid benefit-sharing obligations that could irreparably skew the scientific record. Scientists may restrict their research to samples collected from countries with lax ABS policies, or might even be tempted to misrepresent the provenance of pathogen samples to avoid entering into protracted and potentially expensive benefit-sharing negotiations. The article concludes that one solution might be to use Material Transfer Agreements as a chain-of-custody tool until such time as policymakers can reconcile the ambiguities and inconsistencies of international pathogen sharing regulations.en_US
dc.languageEnglishen_US
dc.publisher.urihttps://www.jscilaw.org/index.php/archivesen_US
dc.relation.ispartofissue2en_US
dc.relation.ispartofjournalThe Journal of Science and Lawen_US
dc.relation.ispartofvolume3en_US
dc.subject.fieldofresearchSociology and social studies of science and technologyen_US
dc.subject.fieldofresearchPublic healthen_US
dc.subject.fieldofresearchEnvironmental and resources lawen_US
dc.subject.fieldofresearchInternational and comparative lawen_US
dc.subject.fieldofresearchcode441007en_US
dc.subject.fieldofresearchcode4206en_US
dc.subject.fieldofresearchcode4802en_US
dc.subject.fieldofresearchcode4803en_US
dc.subject.keywordsConvention on Biological Diversityen_US
dc.subject.keywordsNagoya Protocolen_US
dc.subject.keywordsAccess and Benefit-Sharingen_US
dc.subject.keywordsGenetic Resourcesen_US
dc.subject.keywordsSovereigntyen_US
dc.titleOn the Origin of Samples: Pathogen Provenance and the Rise of the Material Transfer Agreementen_US
dc.typeJournal articleen_US
dc.type.descriptionC2 - Articles (Other)en_US
dcterms.bibliographicCitationRourke, M, On the Origin of Samples: Pathogen Provenance and the Rise of the Material Transfer Agreement, The Journal of Science and Law, 2017, 3 (2)en_US
dc.date.updated2021-12-20T03:34:09Z
gro.hasfulltextNo Full Text
gro.griffith.authorRourke, Michelle F.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record